|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,725.70 INR | -0.54% |
|
-1.08% | +26.47% |
| 05-06 | Emcure Pharmaceuticals Scouts for M&As | CI |
| 05-06 | Jefferies Adjusts Emcure Pharmaceuticals' Price Target to INR1,970 From INR1,780, Keeps at Buy | MT |
| Market Cap | 327B 3.47B 2.99B 2.75B 2.59B 4.86B 4.9B 32.59B 12.69B 161B 13.01B 12.73B 555B | P/E 2026 |
32.7x | P/E 2027 * | 28.6x |
|---|---|---|---|---|---|
| Enterprise Value | 334B 3.54B 3.05B 2.81B 2.64B 4.96B 5.01B 33.26B 12.95B 164B 13.28B 13B 567B | EV / Sales 2026 |
3.33x | EV / Sales 2027 * | 3.18x |
| Free-Float |
18.29% | Yield 2026 |
0.23% | Yield 2027 * | 0.22% |
Last Transcript: Emcure Pharmaceuticals Limited
| 1 day | -0.54% | ||
| 1 week | -1.08% | ||
| Current month | +1.75% | ||
| 1 month | +1.22% | ||
| 3 months | +18.33% | ||
| 6 months | +24.92% | ||
| Current year | +26.47% |
| 1 week | 1,679 |  | 1,760 |
| 1 month | 1,660 | | 1,818 |
| Current year | 1,381 | | 1,830 |
| 1 year | 1,228.9 | | 1,830 |
| 3 years | 889 | | 1,830 |
| 5 years | 889 | | 1,830 |
| 10 years | 889 | | 1,830 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 1981-04-15 | |
| Director of Finance/CFO | - | 2003-09-30 | |
| Compliance Officer | - | 2026-02-03 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 72 | 2001-07-22 | |
| Chairman | 69 | - | |
| Director/Board Member | 75 | 1981-04-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.54% | -1.08% | +29.38% | - | 3.48B | |
| -0.71% | -1.96% | +40.80% | +146.51% | 1,001B | |
| -1.06% | -2.35% | +52.83% | +41.89% | 566B | |
| -0.35% | -1.65% | +19.28% | +60.53% | 393B | |
| +3.82% | +2.29% | +24.04% | +16.53% | 326B | |
| +1.09% | +1.65% | +26.61% | +33.19% | 276B | |
| +1.42% | +0.06% | +26.36% | +15.68% | 277B | |
| +1.87% | +0.87% | -41.49% | -47.26% | 193B | |
| -1.24% | +1.64% | +18.35% | +50.17% | 188B | |
| -1.67% | +3.06% | +15.92% | +61.11% | 158B | |
| Average | -0.26% | +0.57% | +21.21% | +42.04% | 338.03B | |
| Weighted average by Cap. | -0.39% | -0.40% | +29.25% | +66.04% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 91.56B 970M 837M 769M 724M 1.36B 1.37B 9.12B 3.55B 44.93B 3.64B 3.56B 155B | 104B 1.11B 954M 877M 825M 1.55B 1.56B 10.39B 4.04B 51.2B 4.15B 4.06B 177B |
| Net income | 9.81B 104M 89.68M 82.45M 77.61M 146M 147M 977M 380M 4.81B 390M 382M 16.66B | 11.4B 121M 104M 95.8M 90.17M 169M 171M 1.14B 442M 5.59B 453M 444M 19.35B |
| Net Debt | 6.75B 71.52M 61.7M 56.72M 53.39M 100M 101M 672M 262M 3.31B 268M 263M 11.46B | 4.56B 48.37M 41.73M 38.36M 36.11M 67.85M 68.42M 455M 177M 2.24B 182M 178M 7.75B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-16 | 1,725.70 ₹ | -0.54% | 196,957 |
| 26-06-16 | 1,735.00 ₹ | +1.72% | 127,413 |
| 26-06-15 | 1,705.60 ₹ | -1.76% | 285,086 |
| 26-06-12 | 1,736.20 ₹ | +3.14% | 115,903 |
| 26-06-11 | 1,683.30 ₹ | -2.77% | 172,728 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EMCURE Stock
Select your edition
All financial news and data tailored to specific country editions
